Manager × security

Orbis Allan Gray Ltd ELV holdings history

Who else holds this security?

ELEVANCE HEALTH INC · CUSIP 036752103 · CIK 1663865

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Orbis Allan Gray Ltd reported 183.19K ELV (shares), valued at $70.85M, or 0.24% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
0.24%
Shares
183.19K
183,191
Reported value
$70.85M
USD

Shares unchanged; reported value increased 32.10%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.24%183,191SEC filingFiled Aug 14, 2026
Q1 20260.23%183,191SEC filingFiled May 15, 2026
Q4 20251.83%1,244,946SEC filingFiled Feb 17, 2026
Q3 20251.81%1,308,118SEC filingFiled Nov 14, 2025
Q2 20255.40%2,855,850SEC filingFiled Aug 14, 2025
Q1 20257.09%2,849,173SEC filingFiled May 15, 2025
Q4 20244.31%2,168,945SEC filingFiled Feb 14, 2025
Q3 20242.49%904,897SEC filingFiled Nov 14, 2024
Q2 20243.12%924,789SEC filingFiled Aug 14, 2024
Q1 20242.98%959,154SEC filingFiled May 15, 2024
Q4 20232.67%901,606SEC filingFiled Feb 14, 2024
Q3 20232.77%885,831SEC filingFiled Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.77%885,831$385.71MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Nov 14, 2023
Q4 20232.67%901,606$425.16MShares increased 1.78%; reported value increased 10.23%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 14, 2024
Q1 20242.98%959,154$497.36MShares increased 6.38%; reported value increased 16.98%, and weight changed +0.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2024
Q2 20243.12%924,789$501.11MShares decreased 3.58%; reported value increased 0.75%, and weight changed +0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2024
Q3 20242.49%904,897$470.55MShares decreased 2.15%; reported value decreased 6.10%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 14, 2024
Q4 20244.31%2,168,945$800.12MShares increased 139.69%; reported value increased 70.04%, and weight changed +1.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 14, 2025
Q1 20257.09%2,849,173$1.24BShares increased 31.36%; reported value increased 54.89%, and weight changed +2.78 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2025
Q2 20255.40%2,855,850$1.11BShares increased 0.23%; reported value decreased 10.37%, and weight changed -1.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2025
Q3 20251.81%1,308,118$422.68MShares decreased 54.20%; reported value decreased 61.95%, and weight changed -3.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 14, 2025
Q4 20251.83%1,244,946$436.42MShares decreased 4.83%; reported value increased 3.25%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 17, 2026
Q1 20260.23%183,191$53.63MShares decreased 85.29%; reported value decreased 87.71%, and weight changed -1.60 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2026
Q2 20260.24%183,191$70.85MShares unchanged; reported value increased 32.10%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2026
Orbis Allan Gray Ltd · ELEVANCE HEALTH INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1663865","quarter":"2026Q2","cusip":"036752103"}

get_institutional_manager_history
{"cik":"1663865","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.